DK0865492T3 - Specifikke bindingselementer for humant carcinoembryonisk antigen; materialer og metoder - Google Patents

Specifikke bindingselementer for humant carcinoembryonisk antigen; materialer og metoder

Info

Publication number
DK0865492T3
DK0865492T3 DK96941758T DK96941758T DK0865492T3 DK 0865492 T3 DK0865492 T3 DK 0865492T3 DK 96941758 T DK96941758 T DK 96941758T DK 96941758 T DK96941758 T DK 96941758T DK 0865492 T3 DK0865492 T3 DK 0865492T3
Authority
DK
Denmark
Prior art keywords
carcinoembryonic antigen
human carcinoembryonic
specific binding
materials
methods
Prior art date
Application number
DK96941758T
Other languages
Danish (da)
English (en)
Inventor
Jane Katharine Osbourn
Deborah Julie Allen
John Gerald Mccafferty
Original Assignee
Cambridge Antibody Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9525004.9A external-priority patent/GB9525004D0/en
Priority claimed from GBGB9610824.6A external-priority patent/GB9610824D0/en
Application filed by Cambridge Antibody Tech filed Critical Cambridge Antibody Tech
Application granted granted Critical
Publication of DK0865492T3 publication Critical patent/DK0865492T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK96941758T 1995-12-07 1996-12-09 Specifikke bindingselementer for humant carcinoembryonisk antigen; materialer og metoder DK0865492T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9525004.9A GB9525004D0 (en) 1995-12-07 1995-12-07 Specific binding members, materials and methods
GBGB9610824.6A GB9610824D0 (en) 1995-12-07 1996-05-23 Specific binding members, materials and methods
GBGB9621295.6A GB9621295D0 (en) 1995-12-07 1996-10-11 Specific binding members,materials and methods
PCT/GB1996/003043 WO1997020932A1 (fr) 1995-12-07 1996-12-09 Elements de liaison specifiques de l'antigene carcinoembryonnaire humain, materiaux et methodes

Publications (1)

Publication Number Publication Date
DK0865492T3 true DK0865492T3 (da) 2001-06-11

Family

ID=27268018

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96941758T DK0865492T3 (da) 1995-12-07 1996-12-09 Specifikke bindingselementer for humant carcinoembryonisk antigen; materialer og metoder

Country Status (10)

Country Link
EP (1) EP0865492B1 (fr)
JP (2) JP2000504204A (fr)
AT (1) ATE200516T1 (fr)
AU (1) AU703319B2 (fr)
CA (1) CA2239519C (fr)
DE (1) DE69612509T2 (fr)
DK (1) DK0865492T3 (fr)
ES (1) ES2157473T3 (fr)
GB (1) GB9621295D0 (fr)
WO (1) WO1997020932A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722131D0 (en) * 1997-10-20 1997-12-17 Medical Res Council Method
SE519405C2 (sv) * 2000-07-19 2003-02-25 Jacob Weitman Tillämpningar för en avancerad digitalkamera som tolkar den tagna bilden utifrån dess informationsinnehåll, såsom att överföra bilden, beordra en tjänst, styra ett flöde mm
EP1427832A4 (fr) 2001-08-17 2006-09-06 Monsanto Technology Llc Genes de methyltransferase et leurs utilisations
GB0130543D0 (en) * 2001-12-20 2002-02-06 Univ Cambridge Tech Human antibodies and their use
US20060141456A1 (en) * 2002-06-12 2006-06-29 Cynthia Edwards Methods and compositions for milieu-dependent binding of a targeted agent to a target
GB0309126D0 (en) * 2003-04-17 2003-05-28 Neutec Pharma Plc Clostridium difficile focussed antibodies
AU2004293502B2 (en) 2003-11-28 2010-12-02 National Research Council Of Canada Anticarcinoma antibodies and uses thereof
JP4942487B2 (ja) * 2003-12-10 2012-05-30 メダレックス インコーポレーティッド Ｉｐ−１０抗体およびその用途
PL1766093T3 (pl) * 2004-02-06 2011-11-30 Univ Massachusetts Przeciwciała przeciw toksynom Clostridium difficile i ich zastosowania
ES2403055T3 (es) * 2004-04-13 2013-05-13 F. Hoffmann-La Roche Ag Anticuerpos anti-P-selectina
GB0414886D0 (en) 2004-07-02 2004-08-04 Neutec Pharma Plc Treatment of bacterial infections
US8551920B2 (en) 2005-02-01 2013-10-08 Morpho Sys AG Libraries and methods for isolating antibodies
US8993715B2 (en) * 2009-07-06 2015-03-31 Canon Kabushiki Kaisha Labeled protein and method for obtaining the same
WO2023180489A1 (fr) 2022-03-23 2023-09-28 Synaffix B.V. Anticorps-conjugués pour le ciblage de tumeurs exprimant un antigène carcinoembryonnaire

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081235A (en) * 1989-07-26 1992-01-14 City Of Hope Chimeric anti-cea antibody
ES2341666T3 (es) * 1991-12-02 2010-06-24 Medimmune Limited Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
GB9317423D0 (en) * 1993-08-21 1993-10-06 Imp Cancer Res Tech Monoclonal antibodies
GB9324807D0 (en) * 1993-12-03 1994-01-19 Cancer Res Campaign Tech Tumour antibody
US5605793A (en) * 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination

Also Published As

Publication number Publication date
EP0865492A1 (fr) 1998-09-23
EP0865492B1 (fr) 2001-04-11
WO1997020932A1 (fr) 1997-06-12
GB9621295D0 (en) 1996-11-27
CA2239519A1 (fr) 1997-06-12
CA2239519C (fr) 2008-09-16
JP2000504204A (ja) 2000-04-11
AU1103697A (en) 1997-06-27
JP4773540B2 (ja) 2011-09-14
AU703319B2 (en) 1999-03-25
DE69612509D1 (de) 2001-05-17
ES2157473T3 (es) 2001-08-16
ATE200516T1 (de) 2001-04-15
JP2009148299A (ja) 2009-07-09
DE69612509T2 (de) 2001-10-18

Similar Documents

Publication Publication Date Title
DK0865492T3 (da) Specifikke bindingselementer for humant carcinoembryonisk antigen; materialer og metoder
MX9602879A (es) Moleculas mutantes de ctla4 y usos de las mismas.
EP0575546A4 (en) Prad1 cyclin and its cdna
JPS56106154A (en) Detection method of hemoglobin in night soil
EP0352761A3 (fr) Antigènes composés d'antigènes classe I du "major histocompatibility complex", leur production et utilisation
DE69433552D1 (de) An den zelloberflächenrezeptor hek bindendes cytokin
DE3380697D1 (en) Monoclonal antibody
MX9804358A (es) Apoptosis inducida por el anticuerpo monoclonal anti-her2.
NO934801L (no) CTL4A reseptor, fusjonsproteiner som inneholder den og anvendelse derav
DK499086D0 (da) Konjugater af trichothecen og anvendelse af samme som terapeutisk substans
MY111682A (en) Altered antibodies and their preparations.
DE69222956D1 (de) Kleinste erkennungseinheit eines pem-mucin-"tandem repeat"-spezifischen monoklonalen antikoerpers
ATE177475T1 (de) Monoklonale antikörper gegen c-kit
NO915082L (no) Fucosyltransferaser involvert i adhesjonsmolekylekspresjon
KR880014109A (ko) 암-관련 항원-특이적 인간 면역 글로불린 및 인간 면역 글로불린 을 생산하는 능력을 갖는 인간/인간 하이브리도마
IL97927A0 (en) Soluble,truncated gamma-interferon receptors
EP0734451A4 (fr) ENTEROTOXINES DE -i(SHIGELLA FLEXNERI) 2a
WO1987007302A3 (fr) ANTICORPS MONOCLONAUX DES RECEPTEURS IgE DES LYMPHOCYTES HUMAINS, HYBRIDOMES PRODUISANT DE TELS ANTICORPS, ET KITS POUR UTILISER CES ANTICORPS
EP0220970A3 (en) Methods for utilizing cell lines which lack human class ii histocompatibility antigens
Kaldany et al. In vitro stimulation of unprimed lymphocytes by allogeneic semi-soluble lymphocyte membrane fragments
de Recondo EUI< ARYOTIC DNA REPLICATION